Amorfix Life Sciences

  • 3403 American Drive, Mississauga,
  • Ontario, Canada, L4V 1T4
  • Tel: 416-847-6898 info@amorfix.com
  • Home
  • Letter From The CEO
  • Company
    • Management
    • Board of Directors
  • Products
    • Product Pipeline
    • Diagnostics
      • Alzheimer's Disease Dx
      • ALS
      • Liver Cancer
    • Therapeutics
      • ALS
      • Cancer
  • Technologies
    • Epitope Protection
    • ProMIS™ and DSE
  • Services
    • A4
    • Assay Development
  • Investor Relations
    • Press Releases 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
    • In the News
    • Events
    • Financial Results
      • 12-13
      • 11-12
      • 10-11
      • 09-10
      • 08-09
      • 07-08
  • Careers
  • Contact
  • 12-13
  • 11-12
  • 10-11
  • 09-10
  • 08-09
  • 07-08
receive news alerts

Financial Results 2007-2008˜

Q1

  • Press Release
  • MD&A
  • Financial Statements

Q2

  • Press Release
  • MD&A
  • Financial Statements

Q3

  • Press Release
  • MD&A
  • Financial Statements

Year End

  • Press Release
  • MD&A
  • Financial Statements
  • Annual General Meeting

  • Home
  • Letter From The CEO
  • Company
    • Management
    • Board of Directors
  • Products
    • Product Pipeline
    • Alzheimer's Disease
    • ALS Diagnostic
    • ALS Therapeutics
    • Cancer Therapeutics
  • Technologies
    • Epitope Protection
    • ProMIS™ and DSE
  • Services
    • A4
    • Assay Development
  • Investor Relations
    • Press Releases
    • In the News
    • Events
    • Financial Results
  • Careers
  • Contact